Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate
2007-02-20
2007-02-20
Balasubramanian, Venkataraman (Department: 1624)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
C514S272000, C544S331000, C544S324000
Reexamination Certificate
active
10954808
ABSTRACT:
The present invention relates to cancer therapy and to novel anticancer agents having a mechanism of action which inhibits telomerase. It also relates to novel chemical compounds as well as their therapeutic application in humans.
REFERENCES:
patent: 5767278 (1998-06-01), Gaeta et al.
patent: 6150360 (2000-11-01), Daeyaen et al.
patent: 11-60573 (1999-03-01), None
patent: WO 93/20056 (1993-10-01), None
patent: WO 2001019825 (2001-03-01), None
Cecil Textbook of Medicine, edited by Bennet, J.C., and Plum F., 20th edition,vol. 1, 1004-1010, 1996.
Mokbel et al., Int. J. Surg. Investig. 2(1) : 85-8, 2000.
Swellan et al. IUBMN Life, 56(8); 483-490, 2004.
Alasia Marcel
Caulfield Thomas
Doerflinger Gilles
Laoui Abdelazize
Mailliet Patrick
Aventis Pharma S.A.
Balasubramanian Venkataraman
Bender Kelly L.
Darkes Paul R.
LandOfFree
Chemical derivatives and their application as antitelomerase... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Chemical derivatives and their application as antitelomerase..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Chemical derivatives and their application as antitelomerase... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3823889